Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 59,377 $ 72,256
Restricted cash 853 154
Short-term deposits 10,390 10,003
Related party 50
Other current assets 821 2,068
Total current assets 71,441 84,531
Non-current assets    
Lease deposit 5
Property and equipment, net 2,092 1,881
In-process research and development ("R&D") 3,798 4,556
Operating lease right-of-use asset 979 1,148
Total non-current assets 6,869 7,590
Total asset 78,310 92,121
Current liabilities    
Trade account payables 1,282 3,253
Other account payables 1,830 2,596
Current portion of lease liabilities 369 375
Total current liabilities 3,481 6,224
Non-current liabilities    
Lease liabilities - net of current portion 665 856
Contingent liabilities 643 585
Total non-current liabilities 1,308 1,441
Commitments and Contingent Liabilities
Shareholders' equity    
Common stock, $0.0001 par value ("Common Stock"); Authorized - 60,000,000 shares as of June 30, 2020 and December 31, 2019. Issued - 23,145,964 as of June 30, 2020 and 22,862,835 as of December 31, 2019. Outstanding - 23,140,264 shares as of June 30, 2020 and 22,862,835 as of December 31, 2019 2 2
Additional paid in capital 127,798 126,626
Accumulated deficit (54,279) (42,172)
Total shareholders' equity 73,521 84,456
Total liabilities and shareholders' equity $ 78,310 $ 92,121